Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2006, Vol. 11 ›› Issue (5): 540-544.

Previous Articles     Next Articles

Effects of proliferation inhibition and apoptosis of resveratrol trinicotinate on HepG2 cells and its mechanism

FAN Hui-ting, XIONG Xiao-yun, CAO Wei1, GAO Zhong-bao, LI Xiao-qiang, JIA Min, MEI Qi-bing   

  1. Department of Pharmacology,1Department of Neurology, Xijing Hospital, the Fourth Military Medical University, Xi'an 710032, Shanxi, China
  • Received:2006-02-20 Revised:2006-03-06 Online:2006-05-26 Published:2020-12-09

Abstract: AIM: To study the effects of resveratrol trinocotinate(ResT), a structure modification compound on the basis of resveratrol, on proliferation inhibition and apoptosis in HepG2 cell line.METHODS: HepG2 cell were cultivated with different concentration of ResT at the different time in vitro.The proliferation inhibition was measured by MTT assay.Hochest staining method was used to determine the apoptosis, and then FCM was used to analyzed the cell cycle distribution and apoptosis rate, Colorimetric assay wasemployed to detect the activation of Caspase-3.RESULTS: ResT caused growth inhibition in a time and dose-dependent manner.After treatment with ResT for 24 h, some cells appeared apoptotic characteris-tics.The flow cytometric profiles revealed that ResT in-duced cell into G1 -phase and cells in S-phase were de-creased, Apoptotic peaks were observed in the cell cycle analysis.The apoptosis rates were 8.7%, 21.1% and 32.7% respectively after treatment for 12, 24, 48 h. Caspase-3was also activated.CONCLUSION: Induction of apoptosis and G1 -phase cell cycle arrest may be respon-sible for the growth inhibition effect of ResT in HepG2 cell.

Key words: resveratrol, resveratrol trinocotinate, HepG2, apoptosis, caspase-3

CLC Number: